Effects of IMR: a randomized controlled trial 139 Supplementary Material The Supplementary Material for this article also includes: - Supplementary Data Sheet 1 Positive decision Erasmus MC. - Supplementary Data Sheet 2 Original study Protocol for the METC. All Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpsyt.2021.723435/full#supplement ary-material Supplementary Table 1 Coefficients, odds ratios and CI’s, predicting non-completion from baseline characteristics B SE(B) p OR 95% CI for OR Lower Upper Intercept 4,385 2,562 0,087 - - - Age -0,027 0,021 0,195 0,973 0,934 1,014 Sex -0,033 0,409 0,936 0,968 0,434 2,157 Education levela 0,975 Middle -0,109 0,487 0,823 0,897 0,345 2,328 High -0,055 0,546 0,919 0,946 0,324 2,761 Diagnosis Psychotic disorders -0,166 0,593 0,780 0,847 0,265 2,707 Mood disorders -0,735 0,603 0,223 0,480 0,147 1,563 Personality disorders -0,534 0,501 0,287 0,586 0,219 1,567 Start of problems > 10 years prior to IMR -0,051 0,454 0,911 0,950 0,390 2,315 IMRS client version -1,149 0,600 0,055 0,317 0,098 1,027 IMRS clinician version -0,097 0,554 0,862 0,908 0,306 2,690 CSES 0,013 0,007 0,076 1,013 0,999 1,028 BSI -0,014 0,301 0,964 0,987 0,547 1,780 MHRM 0,004 0,018 0,840 1,004 0,969 1,039 a reference category = low; IMRS= Illness Management and Recovery Scale; CSES= Coping Self Efficacy Scale; BSI= Brief Symptom Inventory; MHRM= Mental Health Recovery Measure. .
RkJQdWJsaXNoZXIy MjY0ODMw